TY - JOUR AU - Chen-Xu, M. AU - Yokose, C. AU - Rai, S. K. AU - Pillinger, M. H. AU - Choi, H. K. PY - 2019 DA - 2019// TI - Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007-2016 JO - Arthritis Rheumatol VL - 71 UR - https://doi.org/10.1002/art.40807 DO - 10.1002/art.40807 ID - Chen-Xu2019 ER - TY - JOUR AU - Elfishawi, M. M. AU - Zleik, N. AU - Kvrgic, Z. AU - Michet, C. J. AU - Crowson, C. S. AU - Matteson, E. L. AU - Bongartz, T. PY - 2018 DA - 2018// TI - The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years JO - J Rheumatol VL - 45 UR - https://doi.org/10.3899/jrheum.170806 DO - 10.3899/jrheum.170806 ID - Elfishawi2018 ER - TY - JOUR AU - Choi, H. K. AU - Curhan, G. PY - 2007 DA - 2007// TI - Independent impact of gout on mortality and risk for coronary heart disease JO - Circulation VL - 116 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.703389 DO - 10.1161/CIRCULATIONAHA.107.703389 ID - Choi2007 ER - TY - STD TI - Christensen JL, Yu W, Tan S, Chu A, Vargas F, Assali M, Shah NR, Reginato AM, Wu WC, Choudhary G, et al. Gout is associated with increased coronary artery calcification and adverse cardiovascular outcomes. JACC Cardiovasc Imaging. 2019;13(3):884–86. ID - ref4 ER - TY - JOUR AU - Zhu, Y. AU - Pandya, B. J. AU - Choi, H. K. PY - 2012 DA - 2012// TI - Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008 JO - Am J Med VL - 125 UR - https://doi.org/10.1016/j.amjmed.2011.09.033 DO - 10.1016/j.amjmed.2011.09.033 ID - Zhu2012 ER - TY - JOUR AU - Keenan, R. T. AU - O'Brien, W. R. AU - Lee, K. H. AU - Crittenden, D. B. AU - Fisher, M. C. AU - Goldfarb, D. S. AU - Krasnokutsky, S. AU - Oh, C. AU - Pillinger, M. H. PY - 2011 DA - 2011// TI - Prevalence of contraindications and prescription of pharmacologic therapies for gout JO - Am J Med VL - 124 UR - https://doi.org/10.1016/j.amjmed.2010.09.012 DO - 10.1016/j.amjmed.2010.09.012 ID - Keenan2011 ER - TY - JOUR AU - Disveld, I. J. M. AU - Fransen, J. AU - Rongen, G. A. AU - Kienhorst, L. B. E. AU - Zoakman, S. AU - Janssens, H. AU - Janssen, M. PY - 2018 DA - 2018// TI - Crystal-proven gout and characteristic gout severity factors are associated with cardiovascular disease JO - J Rheumatol VL - 45 UR - https://doi.org/10.3899/jrheum.170555 DO - 10.3899/jrheum.170555 ID - Disveld2018 ER - TY - JOUR AU - Clarson, L. E. AU - Hider, S. L. AU - Belcher, J. AU - Heneghan, C. AU - Roddy, E. AU - Mallen, C. D. PY - 2015 DA - 2015// TI - Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-205252 DO - 10.1136/annrheumdis-2014-205252 ID - Clarson2015 ER - TY - JOUR AU - Pagidipati, N. J. AU - Hess, C. N. AU - Clare, R. M. AU - Akerblom, A. AU - Tricoci, P. AU - Wojdyla, D. AU - Keenan, R. T. AU - James, S. AU - Held, C. AU - Mahaffey, K. W. PY - 2017 DA - 2017// TI - An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome JO - Am Heart J VL - 187 UR - https://doi.org/10.1016/j.ahj.2017.02.023 DO - 10.1016/j.ahj.2017.02.023 ID - Pagidipati2017 ER - TY - JOUR AU - Hansson, G. K. PY - 2005 DA - 2005// TI - Inflammation, atherosclerosis, and coronary artery disease JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMra043430 DO - 10.1056/NEJMra043430 ID - Hansson2005 ER - TY - JOUR AU - Yip, K. AU - Cohen, R. E. AU - Pillinger, M. H. PY - 2020 DA - 2020// TI - Asymptomatic hyperuricemia: is it really asymptomatic? JO - Curr Opin Rheumatol VL - 32 UR - https://doi.org/10.1097/BOR.0000000000000679 DO - 10.1097/BOR.0000000000000679 ID - Yip2020 ER - TY - JOUR AU - Khanna, D. AU - Fitzgerald, J. D. AU - Khanna, P. P. AU - Bae, S. AU - Singh, M. K. AU - Neogi, T. AU - Pillinger, M. H. AU - Merill, J. AU - Lee, S. AU - Prakash, S. PY - 2012 DA - 2012// TI - 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia JO - Arthritis Care Res (Hoboken) VL - 64 UR - https://doi.org/10.1002/acr.21772 DO - 10.1002/acr.21772 ID - Khanna2012 ER - TY - JOUR AU - Richette, P. AU - Doherty, M. AU - Pascual, E. AU - Barskova, V. AU - Becce, F. AU - Castañeda-Sanabria, J. AU - Coyfish, M. AU - Guillo, S. AU - Jansen, T. L. AU - Janssens, H. PY - 2017 DA - 2017// TI - 2016 updated EULAR evidence-based recommendations for the management of gout JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-209707 DO - 10.1136/annrheumdis-2016-209707 ID - Richette2017 ER - TY - JOUR AU - FitzGerald, J. D. AU - Dalbeth, N. AU - Mikuls, T. AU - Brignardello-Petersen, R. AU - Guyatt, G. AU - Abeles, A. M. AU - Gelber, A. C. AU - Harrold, L. R. AU - Khanna, D. AU - King, C. PY - 2020 DA - 2020// TI - 2020 American College of Rheumatology Guideline for the Management of Gout JO - Arthritis Rheumatol VL - 72 UR - https://doi.org/10.1002/art.41247 DO - 10.1002/art.41247 ID - FitzGerald2020 ER - TY - JOUR AU - Khanna, D. AU - Khanna, P. P. AU - Fitzgerald, J. D. AU - Singh, M. K. AU - Bae, S. AU - Neogi, T. AU - Pillinger, M. H. AU - Merill, J. AU - Lee, S. AU - Prakash, S. PY - 2012 DA - 2012// TI - 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis JO - Arthritis Care Res (Hoboken) VL - 64 UR - https://doi.org/10.1002/acr.21773 DO - 10.1002/acr.21773 ID - Khanna2012 ER - TY - JOUR AU - Crittenden, D. B. AU - Lehmann, R. A. AU - Schneck, L. AU - Keenan, R. T. AU - Shah, B. AU - Greenberg, J. D. AU - Cronstein, B. N. AU - Sedlis, S. P. AU - Pillinger, M. H. PY - 2012 DA - 2012// TI - Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout JO - J Rheumatol VL - 39 UR - https://doi.org/10.3899/jrheum.111533 DO - 10.3899/jrheum.111533 ID - Crittenden2012 ER - TY - JOUR AU - Solomon, D. H. AU - Liu, C. C. AU - Kuo, I. H. AU - Zak, A. AU - Kim, S. C. PY - 2016 DA - 2016// TI - Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207984 DO - 10.1136/annrheumdis-2015-207984 ID - Solomon2016 ER - TY - JOUR AU - Nidorf, S. M. AU - Eikelboom, J. W. AU - Thompson, P. L. PY - 2014 DA - 2014// TI - Colchicine for secondary prevention of cardiovascular disease JO - Curr Atheroscler Rep VL - 16 UR - https://doi.org/10.1007/s11883-013-0391-z DO - 10.1007/s11883-013-0391-z ID - Nidorf2014 ER - TY - JOUR AU - Tardif, J. C. AU - Kouz, S. AU - Waters, D. D. AU - OF, B. AU - Diaz, R. AU - Maggioni, A. P. AU - Pinto, F. J. AU - Ibrahim, R. AU - Gamra, H. AU - Kiwan, G. S. PY - 2019 DA - 2019// TI - Efficacy and safety of low-dose colchicine after myocardial infarction JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1912388 DO - 10.1056/NEJMoa1912388 ID - Tardif2019 ER - TY - JOUR AU - Singh, J. A. AU - Ramachandaran, R. AU - Yu, S. AU - Curtis, J. R. PY - 2017 DA - 2017// TI - Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes JO - BMC Cardiovasc Disord VL - 17 UR - https://doi.org/10.1186/s12872-017-0513-6 DO - 10.1186/s12872-017-0513-6 ID - Singh2017 ER - TY - JOUR AU - Dubreuil, M. AU - Zhu, Y. AU - Zhang, Y. AU - Seeger, J. D. AU - Lu, N. AU - Rho, Y. H. AU - Choi, H. K. PY - 2015 DA - 2015// TI - Allopurinol initiation and all-cause mortality in the general population JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-205269 DO - 10.1136/annrheumdis-2014-205269 ID - Dubreuil2015 ER - TY - JOUR AU - Goicoechea, M. AU - Vinuesa, S. G. AU - Verdalles, U. AU - Ruiz-Caro, C. AU - Ampuero, J. AU - Rincon, A. AU - Arroyo, D. AU - Luno, J. PY - 2010 DA - 2010// TI - Effect of allopurinol in chronic kidney disease progression and cardiovascular risk JO - Clin J Am Soc Nephrol VL - 5 UR - https://doi.org/10.2215/CJN.01580210 DO - 10.2215/CJN.01580210 ID - Goicoechea2010 ER - TY - JOUR AU - Larsen, K. S. AU - Pottegard, A. AU - Lindegaard, H. M. AU - Hallas, J. PY - 2016 DA - 2016// TI - Effect of allopurinol on cardiovascular outcomes in hyperuricemic patients: a cohort study JO - Am J Med VL - 129 UR - https://doi.org/10.1016/j.amjmed.2015.11.003 DO - 10.1016/j.amjmed.2015.11.003 ID - Larsen2016 ER - TY - JOUR AU - Ridker, P. M. AU - Everett, B. M. AU - Thuren, T. AU - MacFadyen, J. G. AU - Chang, W. H. AU - Ballantyne, C. AU - Fonseca, F. AU - Nicolau, J. AU - Koenig, W. AU - Anker, S. D. PY - 2017 DA - 2017// TI - Antiinflammatory therapy with canakinumab for atherosclerotic disease JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1707914 DO - 10.1056/NEJMoa1707914 ID - Ridker2017 ER - TY - JOUR AU - Krasnokutsky, S. AU - Romero, A. G. AU - Bang, D. AU - Pike, V. C. AU - Shah, B. AU - Igel, T. F. AU - Dektiarev, I. AU - Guo, Y. AU - Zhong, J. AU - Katz, S. D. PY - 2018 DA - 2018// TI - Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein JO - Clin Rheumatol VL - 37 UR - https://doi.org/10.1007/s10067-018-4029-y DO - 10.1007/s10067-018-4029-y ID - Krasnokutsky2018 ER - TY - JOUR AU - Yeboah, J. AU - Folsom, A. R. AU - Burke, G. L. AU - Johnson, C. AU - Polak, J. F. AU - Post, W. AU - Lima, J. A. AU - Crouse, J. R. AU - Herrington, D. M. PY - 2009 DA - 2009// TI - Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.864801 DO - 10.1161/CIRCULATIONAHA.109.864801 ID - Yeboah2009 ER - TY - JOUR AU - Yeboah, J. AU - Crouse, J. R. AU - Hsu, F. C. AU - Burke, G. L. AU - Herrington, D. M. PY - 2007 DA - 2007// TI - Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study JO - Circulation VL - 115 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.678276 DO - 10.1161/CIRCULATIONAHA.106.678276 ID - Yeboah2007 ER - TY - JOUR AU - Villano, A. AU - Mencarelli, E. AU - Melita, V. AU - Rizzi, A. AU - Lamendola, P. AU - Vita, A. AU - Manfredonia, L. AU - Ravenna, S. E. AU - Pitocco, D. AU - Lanza, G. A. PY - 2020 DA - 2020// TI - Endothelial dysfunction and cardiovascular outcome in asymptomatic patients with type 2 diabetes: a pilot study JO - Diabetes Metab Res Rev VL - 36 UR - https://doi.org/10.1002/dmrr.3215 DO - 10.1002/dmrr.3215 ID - Villano2020 ER - TY - JOUR AU - Irace, C. AU - Rosa, S. AU - Tripolino, C. AU - Ambrosio, G. AU - Covello, C. AU - Abramo, E. AU - Carallo, C. AU - Mongiardo, A. AU - Spaccarotella, C. AU - Torella, D. PY - 2018 DA - 2018// TI - Delayed flow-mediated vasodilation and critical coronary stenosis JO - J Investig Med VL - 66 UR - https://doi.org/10.1136/jim-2017-000644 DO - 10.1136/jim-2017-000644 ID - Irace2018 ER - TY - JOUR AU - Choi, Y. -. J. AU - Yoon, Y. AU - Lee, K. -. Y. AU - Hien, T. T. AU - Kang, K. W. AU - Kim, K. -. C. AU - Lee, J. AU - Lee, M. -. Y. AU - Lee, S. M. AU - Kang, D. -. H. PY - 2014 DA - 2014// TI - Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis JO - FASEB J VL - 28 UR - https://doi.org/10.1096/fj.13-247148 DO - 10.1096/fj.13-247148 ID - Choi2014 ER - TY - JOUR AU - Khosla, U. M. AU - Zharikov, S. AU - Finch, J. L. AU - Nakagawa, T. AU - Roncal, C. AU - Mu, W. AU - Krotova, K. AU - Block, E. R. AU - Prabhakar, S. AU - Johnson, R. J. PY - 2005 DA - 2005// TI - Hyperuricemia induces endothelial dysfunction JO - Kidney Int VL - 67 UR - https://doi.org/10.1111/j.1523-1755.2005.00273.x DO - 10.1111/j.1523-1755.2005.00273.x ID - Khosla2005 ER - TY - JOUR AU - Neogi, T. AU - Jansen, T. L. AU - Dalbeth, N. AU - Fransen, J. AU - Schumacher, H. R. AU - Berendsen, D. AU - Brown, M. AU - Choi, H. AU - Edwards, N. L. AU - Janssens, H. J. PY - 2015 DA - 2015// TI - 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2015-208237 DO - 10.1136/annrheumdis-2015-208237 ID - Neogi2015 ER - TY - JOUR AU - Zheng, H. AU - Cable, R. AU - Spencer, B. AU - Votto, N. AU - Katz, S. D. PY - 2005 DA - 2005// TI - Iron stores and vascular function in voluntary blood donors JO - Arterioscler Thromb Vasc Biol VL - 25 UR - https://doi.org/10.1161/01.ATV.0000174126.28201.61 DO - 10.1161/01.ATV.0000174126.28201.61 ID - Zheng2005 ER - TY - JOUR AU - Zheng, H. AU - Patel, M. AU - Cable, R. AU - Young, L. AU - Katz, S. D. PY - 2007 DA - 2007// TI - Insulin sensitivity, vascular function, and iron stores in voluntary blood donors JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc07-0748 DO - 10.2337/dc07-0748 ID - Zheng2007 ER - TY - JOUR AU - Corretti, M. C. AU - Anderson, T. J. AU - Benjamin, E. J. AU - Celermajer, D. AU - Charbonneau, F. AU - Creager, M. A. AU - Deanfield, J. AU - Drexler, H. AU - Gerhard-Herman, M. AU - Herrington, D. PY - 2002 DA - 2002// TI - Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force JO - J Am Coll Cardiol VL - 39 UR - https://doi.org/10.1016/S0735-1097(01)01746-6 DO - 10.1016/S0735-1097(01)01746-6 ID - Corretti2002 ER - TY - JOUR AU - Jelani, Q. U. AU - Norcliffe-Kaufmann, L. AU - Kaufmann, H. AU - Katz, S. D. PY - 2015 DA - 2015// TI - Vascular endothelial function and blood pressure regulation in afferent autonomic failure JO - Am J Hypertens VL - 28 UR - https://doi.org/10.1093/ajh/hpu144 DO - 10.1093/ajh/hpu144 ID - Jelani2015 ER - TY - JOUR AU - Kanbay, M. AU - Huddam, B. AU - Azak, A. AU - Solak, Y. AU - Kadioglu, G. K. AU - Kirbas, I. AU - Duranay, M. AU - Covic, A. AU - Johnson, R. J. PY - 2011 DA - 2011// TI - A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function JO - Clin J Am Soc Nephrol VL - 6 UR - https://doi.org/10.2215/CJN.11451210 DO - 10.2215/CJN.11451210 ID - Kanbay2011 ER - TY - JOUR AU - Nidorf, M. AU - Thompson, P. L. PY - 2007 DA - 2007// TI - Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease JO - Am J Cardiol VL - 99 UR - https://doi.org/10.1016/j.amjcard.2006.10.039 DO - 10.1016/j.amjcard.2006.10.039 ID - Nidorf2007 ER - TY - JOUR AU - Harris, P. A. AU - Taylor, R. AU - Thielke, R. AU - Payne, J. AU - Gonzalez, N. AU - Conde, J. G. PY - 2009 DA - 2009// TI - Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support JO - J Biomed Inform VL - 42 UR - https://doi.org/10.1016/j.jbi.2008.08.010 DO - 10.1016/j.jbi.2008.08.010 ID - Harris2009 ER - TY - JOUR AU - Jelani, Q. U. AU - Harchandani, B. AU - Cable, R. G. AU - Guo, Y. AU - Zhong, H. AU - Hilbert, T. AU - Newman, J. D. AU - Katz, S. D. PY - 2018 DA - 2018// TI - Effects of serial phlebotomy on vascular endothelial function: results of a prospective double-blind randomized study JO - Cardiovasc Ther VL - 36 UR - https://doi.org/10.1111/1755-5922.12470 DO - 10.1111/1755-5922.12470 ID - Jelani2018 ER - TY - JOUR AU - Schroeder, E. C. AU - Lane-Cordova, A. D. AU - Ranadive, S. M. AU - Baynard, T. AU - Fernhall, B. PY - 2018 DA - 2018// TI - Influence of fitness and age on the endothelial response to acute inflammation JO - Exp Physiol VL - 103 UR - https://doi.org/10.1113/EP086922 DO - 10.1113/EP086922 ID - Schroeder2018 ER - TY - JOUR AU - Ridker, P. M. AU - Buring, J. E. AU - Cook, N. R. AU - Rifai, N. PY - 2003 DA - 2003// TI - C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000055014.62083.05 DO - 10.1161/01.CIR.0000055014.62083.05 ID - Ridker2003 ER - TY - JOUR AU - Ridker, P. M. AU - Rifai, N. AU - Stampfer, M. J. AU - Hennekens, C. H. PY - 2000 DA - 2000// TI - Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men JO - Circulation VL - 101 UR - https://doi.org/10.1161/01.CIR.101.15.1767 DO - 10.1161/01.CIR.101.15.1767 ID - Ridker2000 ER - TY - JOUR AU - Galea, J. AU - Armstrong, J. AU - Gadsdon, P. AU - Holden, H. AU - Francis, S. E. AU - Holt, C. M. PY - 1996 DA - 1996// TI - Interleukin-1 beta in coronary arteries of patients with ischemic heart disease JO - Arterioscler Thromb Vasc Biol VL - 16 UR - https://doi.org/10.1161/01.ATV.16.8.1000 DO - 10.1161/01.ATV.16.8.1000 ID - Galea1996 ER - TY - JOUR AU - Ridker, P. M. PY - 2013 DA - 2013// TI - Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? JO - Curr Atheroscler Rep VL - 15 UR - https://doi.org/10.1007/s11883-012-0295-3 DO - 10.1007/s11883-012-0295-3 ID - Ridker2013 ER - TY - JOUR AU - Ridker, P. M. AU - MacFadyen, J. G. AU - Everett, B. M. AU - Libby, P. AU - Thuren, T. AU - Glynn, R. J. PY - 2018 DA - 2018// TI - Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(17)32814-3 DO - 10.1016/S0140-6736(17)32814-3 ID - Ridker2018 ER - TY - JOUR AU - Baldus, S. AU - Heeschen, C. AU - Meinertz, T. AU - Zeiher, A. M. AU - Eiserich, J. P. AU - Munzel, T. AU - Simoons, M. L. AU - Hamm, C. W. PY - 2003 DA - 2003// TI - Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000090690.67322.51 DO - 10.1161/01.CIR.0000090690.67322.51 ID - Baldus2003 ER - TY - JOUR AU - Rajendra, N. S. AU - Ireland, S. AU - George, J. AU - Belch, J. J. AU - Lang, C. C. AU - Struthers, A. D. PY - 2011 DA - 2011// TI - Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris JO - J Am Coll Cardiol VL - 58 UR - https://doi.org/10.1016/j.jacc.2010.12.052 DO - 10.1016/j.jacc.2010.12.052 ID - Rajendra2011 ER - TY - JOUR AU - Feig, D. I. AU - Soletsky, B. AU - Johnson, R. J. PY - 2008 DA - 2008// TI - Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JO - Jama VL - 300 UR - https://doi.org/10.1001/jama.300.8.924 DO - 10.1001/jama.300.8.924 ID - Feig2008 ER - TY - JOUR AU - Jalal, D. I. AU - Decker, E. AU - Perrenoud, L. AU - Nowak, K. L. AU - Bispham, N. AU - Mehta, T. AU - Smits, G. AU - You, Z. AU - Seals, D. AU - Chonchol, M. PY - 2017 DA - 2017// TI - Vascular function and uric acid-lowering in stage 3 CKD JO - J Am Soc Nephrol VL - 28 UR - https://doi.org/10.1681/ASN.2016050521 DO - 10.1681/ASN.2016050521 ID - Jalal2017 ER - TY - JOUR AU - Golenbiewski, J. AU - Keenan, R. T. PY - 2019 DA - 2019// TI - Moving the needle: improving the care of the gout patient JO - Rheumatol Ther VL - 6 UR - https://doi.org/10.1007/s40744-019-0147-5 DO - 10.1007/s40744-019-0147-5 ID - Golenbiewski2019 ER - TY - JOUR AU - Kang, D. H. AU - Han, L. AU - Ouyang, X. AU - Kahn, A. M. AU - Kanellis, J. AU - Li, P. AU - Feng, L. AU - Nakagawa, T. AU - Watanabe, S. AU - Hosoyamada, M. PY - 2005 DA - 2005// TI - Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter JO - Am J Nephrol VL - 25 UR - https://doi.org/10.1159/000087713 DO - 10.1159/000087713 ID - Kang2005 ER - TY - JOUR AU - Kirca, M. AU - Oguz, N. AU - Cetin, A. AU - Uzuner, F. AU - Yesilkaya, A. PY - 2017 DA - 2017// TI - Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRbeta JO - J Recept Signal Transduct Res VL - 37 UR - https://doi.org/10.1080/10799893.2016.1203941 DO - 10.1080/10799893.2016.1203941 ID - Kirca2017 ER - TY - JOUR AU - Ives, A. AU - Nomura, J. AU - Martinon, F. AU - Roger, T. AU - LeRoy, D. AU - Miner, J. N. AU - Simon, G. AU - Busso, N. AU - So, A. PY - 2015 DA - 2015// TI - Xanthine oxidoreductase regulates macrophage IL1beta secretion upon NLRP3 inflammasome activation JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms7555 DO - 10.1038/ncomms7555 ID - Ives2015 ER - TY - STD TI - Shah B, Toprover M, Crittenden DB, Jeurling S, Pike VC, Krasnokutsky S, Xia Y, Fisher MC, Slobodnick A, Tenner CT, et al. Colchicine use and incident coronary artery disease in male patients with gout. Can J Cardiol. 2020. Online ahead of print. ID - ref55 ER - TY - JOUR AU - Seropian, I. M. AU - Toldo, S. AU - Tassell, B. W. AU - Abbate, A. PY - 2014 DA - 2014// TI - Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2014.01.014 DO - 10.1016/j.jacc.2014.01.014 ID - Seropian2014 ER - TY - STD TI - FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat). https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloricfebuxostat. Accessed 7 July 2020. UR - https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloricfebuxostat ID - ref57 ER - TY - JOUR AU - White, W. B. AU - Saag, K. G. AU - Becker, M. A. AU - Borer, J. S. AU - Gorelick, P. B. AU - Whelton, A. AU - Hunt, B. AU - Castillo, M. AU - Gunawardhana, L. AU - Investigators, C. PY - 2018 DA - 2018// TI - Cardiovascular safety of febuxostat or allopurinol in patients with gout JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1710895 DO - 10.1056/NEJMoa1710895 ID - White2018 ER -